Ullrich congenital muscular dystrophy: сlinical case study
https://doi.org/10.25789/YMJ.2024.86.23
Abstract
Introduction. Ullrich congenital muscular dystrophy (Ullrich СMD, OMIM #254090) is the most severe form of skeletal muscle collagenopathy associated with three genes (COL6A1, COL6A2, COL6A3).
The purpose of the report was to present our own observation of clinical cases with Ullrich congenital muscular dystrophy in two unrelated Yakut families.
Materials and methods. A clinical and genealogical examination, electroneuromyography, muscle MRI, muscle biopsy, and molecular genetic research using the massively parallel sequencing method were carried out.
Results. The cause of the disease in the first family was two mutations in a compound heterozygous state: c.1561C>T and c.2329T>C in the COL6A2 gene; in the second family, the c.2329T>C mutation in the COL6A2 gene in a homozygous state. The clinical picture of the disease was manifested by muscle weakness and hypotonia, hypermobility of the interphalangeal joints, contractures of the elbow, ankle and knee joints, delayed motor development, spinal deformity, and skin changes. The type of inheritance in families is autosomal recessive.
Conclusions. Despite the rarity of the disease, neurologists and geneticists, when identifying symptoms of myopathy, delayed motor development, and the presence of hypermobility in the distal joints, contrasting with retractions of the proximal and axial joints, must be alert to Ullrich CMD. Next-generation sequencing techniques make it easier to diagnose the disease.
About the Authors
P. I. GolikovaRussian Federation
Golikova Polina Innokentievna – PhD, senior researcher
G. D. Moskvitin
Russian Federation
Moskvitin Gavril Dmitrievich – junior researcher
A. L. Sukhomyasova
Russian Federation
Sukhomyasova Aitalina Lukichna – PhD, Visiting Research Fellow
E. E. Gurinova
Russian Federation
Gurinova Elizaveta Egorovna – geneticist
I. A. Nikolaeva
Russian Federation
Nikolaeva Irina Averyevna – geneticist
R. N. Ivanova
Russian Federation
Ivanova Roza Nikolaevna – junior researcher
V. M. Sofronova
Russian Federation
Sofronova Victoria Maksimovna – researcher
N. R. Maksimova
Russian Federation
Maksimova Nadezhda Romanovna – MD, chief researcher
References
1. Congenital muscular dystrophies: classification and diagnostic strategy / Rivier F. [et al.] // Neuromuscular Diseases. 2014. Vol. 1. P. 6-20. https://doi.org/10.17650/2222-8721-2014-0-1-6-14.
2. Ovsova O.V., Michaylova E.P. Сlinical case of a patient with Ulrich congenital muscular dystrophy // Ural medical journal. 2019. Vol. 13 (181). P. 66-68. DOI: 10.25694/ UKMJ.2019.13.19.
3. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Betlem myopathy / Lampe AK [et al.]. J Med Genet. 2005. Vol. 42. P. 108-120. DOI: 10.1136/img.2004.023754.
4. Bӧnnemann C.G. The collagen VI-related myopathies: Ullrich congenital muscular dystrophy and Bethlem myopathy // Handb Clin Neurol. 2011. Vol. 101. P. 81-96. DOI: 10.1016/B978-0-08-045031-5.00005-0.
5. Bushby K., Collins J., Hicks D. Collagen Type VI Myopathies // Adv Exp Med Biol. 2014. Vol. 802. P. 185-99. DOI: 10.1007/978-94-007-7893-1_12.
6. Clinical features of collagen VI-related dystrophies: a large Brazilian cohort / Zanoteli E. [et al.] // Clinical Neurology and Neurosurgery. 2020. Vol. 192. P. 105734. DOI: 10.1016/j.clineuro.2020.105734
7. https://www.ncbi.nlm.nih.gov/clinvar/variation/17166/
8. https://www.ncbi.nlm.nih.gov/clinvar/variation/423719/
9. Lampe AK, Bushby KM. Collagen VI related muscle disorders // J Med Genet. – 2005. Vol. 42. P. 673-685. DOI: 10.1136/jmg.2002.002311.
10. Natural history of pulmonary function in collagen VI-related myopathies / Foley A.R. [et al.] // Brain. 2013. Vol. 136. P. 3625-3633. DOI: 10.1093/brain/awt284
11. Natural history of Ullrich congenital muscular dystrophy / Nadeau A. [et al.] Neurology. 2009. Vol. 73. P. 25-31. DOI: 10.1212/WNL.0b013e3181aae851
12. New Molecular Mechanism for Ulrich Congenital Muscular Dystrophy: A Heterozygous In-Frame Deletion in the COL6A1 / Pan T.-C. [et al.] // Gene Causes a Severe Phenotype. Am. J. Hum. Genet. 2003. Vol. 73. P. 355-369. DOI: 10.1086/377107
13. Overexpression of miR-29 Leads to Myopathy that Resemble Pathology of Ulrich Congenital Muscular Dystrophy / Liu C. [et al.] // Cells. 2019. Vol. 8. P. 459. DOI: 10.3390/cells8050459.
14. Prevalence of genetic muscle disease in Northern England: indepth analysis of a muscle clinic population / Norwood F.L.M. [et al.]. // Brain. 2009. Vol. 132(011). P. 3175-3186. DOI: 10.1093/brain/awp236
15. Ullrich Congenital Muscular Dystrophy (UCMD): Clinical and Genetic Correlations / Bozorgmehr, B. [et al.] // Iranian journal of child neurology. 2013. Vol. 7(3). P. 15–22.
16. Yonekawa T., Nishino I. Ulrich congenital muscular dystrophy: clinicopathological features, natural history and pathomechanism(s) // J Neurol Neurosurg Psychiatry. 2014. Vol. 0. P. 1-8. DOI: 10.1136/jnnp-2013-307052.
Review
For citations:
Golikova P.I., Moskvitin G.D., Sukhomyasova A.L., Gurinova E.E., Nikolaeva I.A., Ivanova R.N., Sofronova V.M., Maksimova N.R. Ullrich congenital muscular dystrophy: сlinical case study. Yakut Medical Journal. 2024;(2):98-102. https://doi.org/10.25789/YMJ.2024.86.23